Page 6 - Thomas Theuringer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million

QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 million
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesDaniela berheideJohn gilardiThomas theuringerPhoebe lohLife sciencesUs securities exchangeExchange commissionNew york stock exchangeFrankfurt stock exchangeYork stock exchangeFrankfurt prime standardDepository trust companyEffective dateDepository trustcompanyClearstream banking

QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Systems

Germantown, Maryland, and Venlo, the Netherlands, Jan. 08, 2024 QIAGEN today announced the U.S. Food and Drug Administration clearance for the NeuMoDx CT/NG Assay 2.0, growing its test menu.

United statesNational institutes of healthThomas theuringerJohn gilardiDaniela berheideFernando beilsPhoebe lohGlobenewswire incUs securities exchangeUs national institutes of healthLife sciencesExchange commissionDrug administrationFrankfurt prime standardNeumodx molecular systemsSenior vice president

QIAGEN announces plans to return approximately $300 million to shareholders

QIAGEN announces plans to return approximately $300 million to shareholders
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Phoebe lohJohn gilardiThomas theuringerDaniela berheideThierry bernardExchange commissionUs securities exchangeLife sciencesFrankfurt prime standardAnnual general meetingChief financial officerShare premium reserveMolecular diagnosticsExchange actAnnual report

QIAGEN announces plans to return approximately $300 million to shareholders

Venlo, the Netherlands, Jan. 07, 2024 QIAGEN N.V. today announced a plan to return up to approximately $300 million to shareholders through a synthetic share repurchase that combines a direct.

Daniela berheidePhoebe lohThierry bernardThomas theuringerJohn gilardiUs securities exchangeExchange commissionGlobenewswire incLife sciencesFrankfurt prime standardAnnual general meetingChief financial officerShare premium reserveExchange actAnnual report

QIAGEN Expands Presence in Middle East with New Riyadh HQ, MoU with Saudi Ministry of Health, and Oman TB Screening Initiative

QIAGEN Expands Presence in Middle East with New Riyadh HQ, MoU with Saudi Ministry of Health, and Oman TB Screening Initiative
news.europawire.eu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.europawire.eu Daily Mail and Mail on Sunday newspapers.

Ministry of healthSaudi arabiaAr riyaSultanate of omanLisa mannagotteraSimona granditsThomas theuringerAlexandra koenigJohn gilardiDaniela berheidePhoebe lohMinistry of health saudi arabiaSaudi ministry of healthWorld health organizationHead of corporate communicationsCorporate communications head